A Phase II study in adult patients with newly diagnosed chronic-phase chronic myeloid leukaemia of initial intensified imatinib therapy and sequential dose-escalation followed by treatment with nilotinib in suboptimal responders to determine the rate and duration of major molecular response (CML09)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-phase-ii-response-cml09/2538348
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: Data for 210 patients with newly diagnosed CML, introducing TKI in a sequential and randomised way. Demographic data, diagnostic data, treatment data, outcome data
提供机构：
Health Data Australia Contributor Records
